KLOW Blend 80mg (BPC-157 10mg + GHK-CU 50mg + TB-500 10mg + KPV 10mg)

KLOW peptide is not a single compound — it is a blend of four: GHK-Cu, BPC-157, TB-500 and KPV, supplied together in one 80mg vial as a lyophilised powder. You will also see it written KLOW blend, KLOW stack or KLOW 80mg.

KLOW combines GHK-Cu, BPC-157, TB-500, and KPV in one vial. (!) Read about each individually: GHK-Cu, BPC-157, TB-500, and KPV.

Both share the same three peptides — GHK-Cu, BPC-157 and TB-500. KLOW adds a fourth, KPV, and comes as an 80mg vial against GLOW's 70mg. If the research question involves KPV's inflammatory-pathway activity, KLOW is the one; otherwise GLOW covers the same three. (!) Compare our GLOW Blend.

KPV is the fourth peptide in KLOW, and the only one GLOW does not contain — a tripeptide from the tail end of the alpha-MSH sequence, studied in inflammatory-pathway research. Buying KPV separately gives you that compound alone at a higher individual quantity; KLOW gives it alongside GHK-Cu, BPC-157 and TB-500 at fixed proportions. (!) View our KPV.

PhaseOne ships the KLOW blend Australia-wide for research use, dispatched locally with tracking, in 80mg vials. Every vial carries a batch-specific Certificate of Analysis verifying ≥99% HPLC purity across all four components.

Yes — PhaseOne has the KLOW blend for sale online in 80mg vials, shipped Australia-wide. With a four-peptide blend the thing to check is whether the Certificate of Analysis covers every component or only one; PhaseOne tests all four per batch.

PhaseOne prices the KLOW blend at A$162.99 for the 80mg vial, with the batch Certificate of Analysis included at no extra cost. The three-peptide GLOW blend, without KPV, is A$143.99.

The blend arrives pre-combined at fixed proportions and needs reconstituting once, which suits designs using all four at a set ratio. Four separate vials cost more in total but let each be varied independently. (!) View GHK-Cu, BPC-157, TB-500 and KPV individually.

No. None of the four peptides in KLOW is registered on the ARTG or approved for supply as a medicine in Australia, so Chemist Warehouse and other Australian chemists do not stock the blend or its components. They are supplied as research compounds through research suppliers instead.

Researchers across Australia studying combined skin, tissue, and inflammatory signalling pathways often choose multi-peptide blends like KLOW to examine several mechanisms within one preparation.

The KLOW Blend should be stored refrigerated, unreconstituted, and protected from light, and is commonly reconstituted with bacteriostatic water prior to research use. (!) Read our reconstitution guide.

Every batch of the KLOW Blend sold across Australia is independently HPLC tested, with a Certificate of Analysis verifying all four peptide components.

Yes - PhaseOne provides a peptide dosage calculator researchers can use as a reference tool when planning reconstitution and dilution. Use our peptide dosage calculator.